Oral Answers to Questions Debate
Full Debate: Read Full DebateSimon Baynes
Main Page: Simon Baynes (Conservative - Clwyd South)Department Debates - View all Simon Baynes's debates with the Foreign, Commonwealth & Development Office
(3 years, 3 months ago)
Commons ChamberThrough our investment in the development of the AstraZeneca vaccine, our finance for COVAX and our commitment of 100 million vaccine doses from surplus domestic supply, the UK is a global leader in our support for vaccinating the poorest around the world.
My hon. Friend is absolutely right. At the G7, by making it clear that we would donate 100 million doses from surplus domestic supply by the end of June 2022, we also leveraged 1 billion doses from other countries. We are committing 80% to COVAX, which will be distributed according to its criteria, and a further 20% on a strategic basis. Allocations will be announced in due course.
Will my right hon. Friend join me in praising the employees of Wockhardt in my constituency of Clwyd South for the indispensable role they have played in our vaccine manufacturing process? It has allowed us not only to roll out doses swiftly and effectively in the UK, but to support countries across the rest of the world that have been badly hit by the covid pandemic.
My hon. Friend can be rightly very proud of the role his constituents have played. It is not only Wockhardt employees, but the wider AstraZeneca collaboration with Government and the £90 million of support that the Government put in for research and development and for getting capacity up that have meant that we not only have this world-beating domestic vaccine roll-out, but have supplied 98% of the vaccine to the poorest and most vulnerable countries around the world delivered by COVAX.